Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 749661

Successful treatment in a patient with moderate- to-severe psoriasis with ustekinumab–case report


Bakija-Konsuo, Ana
Successful treatment in a patient with moderate- to-severe psoriasis with ustekinumab–case report // Abstract book 2nd/19th Congress of Serbian Association of Dermatovenereologists
Beograd, Srbija, 2013. (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 749661 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Successful treatment in a patient with moderate- to-severe psoriasis with ustekinumab–case report

Autori
Bakija-Konsuo, Ana

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstract book 2nd/19th Congress of Serbian Association of Dermatovenereologists / - , 2013

Skup
2/19 Kongres udruženja dermatovenerologa Srbije

Mjesto i datum
Beograd, Srbija, 13.06.2013. - 14.06.2013

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
psoriasis; ustekinumab; side effects

Sažetak
We present a patient with long-standing, moderate-to-severe plaque psoriasis.He had a history of PV since the age of 38. His comorbidities included arterial hypertension and hyperlipidemia. The patient was anxious, the pruritus was extremely strong distracting him in everyday activities. His previous treatments included topical therapies (topical corticosteroids, vitamin D derivates), phototherapy and acitretin which were not effective or not tolerated. In June 2011 a treatment with ustekinumab was introduced at a dose of 90mg (107 kg) at week 0 and 4. After this injections of ustekinumab skin lesions were greatly improved. He continued treatment every 12 weeks. 18 monhts after the first injection there is only minimal disease activity, without any complication. The patient is extremely satisfied, he forgot his disease, he lost weight, and he successfully manages his everydays activities. In conclusion, this case report had demonstrated a high efficacy of the treatment with ustekinumab in our patient. The compliance is very good because of dosing every 12 weeks. The most improtant fact is the significant improvment of quality of life in our patient.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Sveučilište u Dubrovniku

Profili:

Avatar Url Ana Bakija-Konsuo (autor)


Citiraj ovu publikaciju:

Bakija-Konsuo, Ana
Successful treatment in a patient with moderate- to-severe psoriasis with ustekinumab–case report // Abstract book 2nd/19th Congress of Serbian Association of Dermatovenereologists
Beograd, Srbija, 2013. (poster, međunarodna recenzija, sažetak, znanstveni)
Bakija-Konsuo, A. (2013) Successful treatment in a patient with moderate- to-severe psoriasis with ustekinumab–case report. U: Abstract book 2nd/19th Congress of Serbian Association of Dermatovenereologists.
@article{article, author = {Bakija-Konsuo, Ana}, year = {2013}, pages = {50}, keywords = {psoriasis, ustekinumab, side effects}, title = {Successful treatment in a patient with moderate- to-severe psoriasis with ustekinumab–case report}, keyword = {psoriasis, ustekinumab, side effects}, publisherplace = {Beograd, Srbija} }
@article{article, author = {Bakija-Konsuo, Ana}, year = {2013}, pages = {50}, keywords = {psoriasis, ustekinumab, side effects}, title = {Successful treatment in a patient with moderate- to-severe psoriasis with ustekinumab–case report}, keyword = {psoriasis, ustekinumab, side effects}, publisherplace = {Beograd, Srbija} }




Contrast
Increase Font
Decrease Font
Dyslexic Font